Freeze Tag Inc (PINKSHEETS: FRZT) slipped 10.71% and closed at $0.025 on a traded volume of 15k shares. The Company’s CEO, Craig Holland updated shareholders on the progress of the company. Grimm Reaper launched in December and has been performing to the Company’s expectations. The Company develops and markets games across various digital distribution platforms, including PC/Mac downloadable; mobile; and social networking sites, such as including Facebook.
Bio Matrix Scientific Group Inc (PINKSHEETS: BMSN) climbed up 3.85% to $0.0027 on a traded volume 6.58 million shares. So far this year, the stock is up over 69%. The 52-week range for the stock is $0.02 and $0.18. The 50-Day Moving Average and 200-Day Moving Average prices is $0.03 and $0.04 respectively. The Company is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.
Superior Venture Corp (OTC: SVEN) slipped 2.78% to $0.0105 on a traded volume of 445k shares. The stock opened at $0.01. The 52-week range for the stock is $0.01 and $0.35. The 50-Day Moving Average and 200-Day Moving Average prices is $0.02 and $0.02 respectively. The organization is a development stage company, intends to produce and sell wine varietals. The Company was founded in April 2010 and is based in Centennial, Colorado.
SWINGPLANE VENTURES (OTC: SWVI) among the top performers and the stock soared 52.76% to $0.26 on a traded volume of 55.75 million shares. The Company has renegotiated its assignment agreement in regard to the acquisition of certain mining concessions in Chile. Under the terms of the newly negotiated agreement, the Company will acquire all the issued and outstanding shares of Mid Americas in exchange for the issuance of a total of 100,000,000 shares of common stock of the Company and 5,000,000 shares of preferred stock of the Company. The preferred stock will be convertible into shares of common stock of the Company on the basis of 50 shares of common stock for each 1 share of preferred stock.
Peregrine Pharmaceuticals (NASDAQ:PPHM) moved down 0.93% to $2.14 on a traded volume of 291k shares. Recently, the Company filed SEC Form 4 related to statement of changes in beneficial ownership of securities.
Roth Capital increased the rating of Peregrine Pharmaceuticals from a neutral rating to a buy rating in a research report released. Roth Capital currently has $2.70 price target on the stock.
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062